Drugs / GN-037
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05428202 | Mar → Apr 2022 | psoriasis | TC Erciyes University | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05706870 | Dec 2022 → Jan 2024 | psoriasis | GEN İlaç ve Sağlık Ürünleri A.Ş. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GN-037 | “The present study aimed to investigate the safety, tolerability, and, to some extent, efficacy of GN-037 cream in patients with psoriasis and healthy volunteers.” PMID 37300792 ↗ Jun 2023 |
| Route | Topical | “GN-037 cream topically applied twice daily for 2 weeks” PMID 37300792 ↗ Jun 2023 |